A blood test based from a South Baltimore lab is making treatment clearer for cancer patients.
HaystackMRD, made by Haystack Oncology within Quest Diagnostics, looks for signs of cancer that conventional methods may miss.
While it’s been in development for many, many years, the test was made clinically available for oncologists and pharmaceutical partners in late 2024.
Finding the remaining cancer
After going through treatments, even surgery, there’s always the possibility that cancer can remain in the body…